Literature DB >> 10030430

Carbamazepine in the treatment of epilepsy in people with intellectual disability.

H Waisburg1, N Alvarez.   

Abstract

Carbamazepine is a major antiepileptic drug which is primarily used to treat epileptic patients suffering from partial seizures with or without secondary generalization, but which also has applications in those suffering from primary generalized tonic-clonic seizures. Besides its antiepileptic effect, carbamazepine is also indicated in the treatment of trigeminal and occipital neuralgia, and in manic depressive disorders. Because of its minimal unwanted effects on cognition and behaviour, carbamazepine is an excellent drug for the treatment of people with intellectual disability and epilepsy. Carbamazepine is still one of the most commonly prescribed medications in the treatment of epileptic disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10030430

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  1 in total

1.  Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats.

Authors:  Haiyan Yang; Rui Zhang; Chen Jia; Mengyu Chen; Wen Yin; Liming Wei; Haisheng Jiao
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.